| Scott W Gibson, MD | |
|
160 Academy Ave, Greenwood, SC 29646-3808 | |
| (864) 223-8090 | |
| (864) 223-4026 |
| Full Name | Scott W Gibson |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 30 Years |
| Location | 160 Academy Ave, Greenwood, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982648549 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 47438-020 (Wisconsin) | Secondary |
| 208600000X | Surgery | 85386 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Home Health Services Of Self Regional Healthcare | Greenwood, SC | Home health agency |
| Self Regional Healthcare | Greenwood, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Self Regional Healthcare Partners | 1557606118 | 18 |
| Self Medical Group | 6002953916 | 281 |
News Archive
Coventry, the creator of the secondary market for life insurance in the U.S., applauds the New York Court of Appeals decision in Kramer v. Phoenix Life Insurance Company as a significant victory for life insurance consumers and the secondary market for life insurance.
GlaxoSmithKline (GSK) Consumer Healthcare today released survey findings that decisively refute the myth that smokers are "sexy." In fact, in a national survey of 784 adults aged 18-44, an overwhelming majority of respondents - 87% - disagreed with the sentiment that smoking is sexy. Adding insult to injury, among all adults, almost one quarter (24%) have actually turned down sex because the potential partner was a smoker.
GenomeDx Biosciences today announced the publication of a positive validation study for the Decipher® Prostate Cancer Classifier, a genomic test for prostate cancer. The study, published in the Journal of Clinical Oncology, showed that patients with low genomic risk (as determined by Decipher) may be optimally managed with observation after radical prostatectomy (prostate surgery), while those with high genomic risk (as determined by Decipher) may be better managed earlier with adjuvant radiotherapy.
Recent research has shown that bone health is compromised in people with diabetes, resulting in a significantly higher risk of fragility fracture.
Albireo AB, a biopharmaceutical company specializing in gastroenterology, today announced that A4250 (an inhibitor of the ileal bile acid transporter, IBAT/ASBT) has been granted orphan-drug designation by the U.S Food and Drug Administration for the treatment of Progressive Familial Intrahepatic Cholestasis (PFIC) and Primary Biliary Cirrhosis (PBC).
› Verified 7 days ago
| Entity Name | Self Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982836847 PECOS PAC ID: 6002953916 Enrollment ID: O20091027000071 |
News Archive
Coventry, the creator of the secondary market for life insurance in the U.S., applauds the New York Court of Appeals decision in Kramer v. Phoenix Life Insurance Company as a significant victory for life insurance consumers and the secondary market for life insurance.
GlaxoSmithKline (GSK) Consumer Healthcare today released survey findings that decisively refute the myth that smokers are "sexy." In fact, in a national survey of 784 adults aged 18-44, an overwhelming majority of respondents - 87% - disagreed with the sentiment that smoking is sexy. Adding insult to injury, among all adults, almost one quarter (24%) have actually turned down sex because the potential partner was a smoker.
GenomeDx Biosciences today announced the publication of a positive validation study for the Decipher® Prostate Cancer Classifier, a genomic test for prostate cancer. The study, published in the Journal of Clinical Oncology, showed that patients with low genomic risk (as determined by Decipher) may be optimally managed with observation after radical prostatectomy (prostate surgery), while those with high genomic risk (as determined by Decipher) may be better managed earlier with adjuvant radiotherapy.
Recent research has shown that bone health is compromised in people with diabetes, resulting in a significantly higher risk of fragility fracture.
Albireo AB, a biopharmaceutical company specializing in gastroenterology, today announced that A4250 (an inhibitor of the ileal bile acid transporter, IBAT/ASBT) has been granted orphan-drug designation by the U.S Food and Drug Administration for the treatment of Progressive Familial Intrahepatic Cholestasis (PFIC) and Primary Biliary Cirrhosis (PBC).
› Verified 7 days ago
| Entity Name | Self Regional Healthcare Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922582105 PECOS PAC ID: 1557606118 Enrollment ID: O20190129003656 |
News Archive
Coventry, the creator of the secondary market for life insurance in the U.S., applauds the New York Court of Appeals decision in Kramer v. Phoenix Life Insurance Company as a significant victory for life insurance consumers and the secondary market for life insurance.
GlaxoSmithKline (GSK) Consumer Healthcare today released survey findings that decisively refute the myth that smokers are "sexy." In fact, in a national survey of 784 adults aged 18-44, an overwhelming majority of respondents - 87% - disagreed with the sentiment that smoking is sexy. Adding insult to injury, among all adults, almost one quarter (24%) have actually turned down sex because the potential partner was a smoker.
GenomeDx Biosciences today announced the publication of a positive validation study for the Decipher® Prostate Cancer Classifier, a genomic test for prostate cancer. The study, published in the Journal of Clinical Oncology, showed that patients with low genomic risk (as determined by Decipher) may be optimally managed with observation after radical prostatectomy (prostate surgery), while those with high genomic risk (as determined by Decipher) may be better managed earlier with adjuvant radiotherapy.
Recent research has shown that bone health is compromised in people with diabetes, resulting in a significantly higher risk of fragility fracture.
Albireo AB, a biopharmaceutical company specializing in gastroenterology, today announced that A4250 (an inhibitor of the ileal bile acid transporter, IBAT/ASBT) has been granted orphan-drug designation by the U.S Food and Drug Administration for the treatment of Progressive Familial Intrahepatic Cholestasis (PFIC) and Primary Biliary Cirrhosis (PBC).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Scott W Gibson, MD 160 Academy Ave, Greenwood, SC 29646-3808 Ph: (864) 223-8090 | Scott W Gibson, MD 160 Academy Ave, Greenwood, SC 29646-3808 Ph: (864) 223-8090 |
News Archive
Coventry, the creator of the secondary market for life insurance in the U.S., applauds the New York Court of Appeals decision in Kramer v. Phoenix Life Insurance Company as a significant victory for life insurance consumers and the secondary market for life insurance.
GlaxoSmithKline (GSK) Consumer Healthcare today released survey findings that decisively refute the myth that smokers are "sexy." In fact, in a national survey of 784 adults aged 18-44, an overwhelming majority of respondents - 87% - disagreed with the sentiment that smoking is sexy. Adding insult to injury, among all adults, almost one quarter (24%) have actually turned down sex because the potential partner was a smoker.
GenomeDx Biosciences today announced the publication of a positive validation study for the Decipher® Prostate Cancer Classifier, a genomic test for prostate cancer. The study, published in the Journal of Clinical Oncology, showed that patients with low genomic risk (as determined by Decipher) may be optimally managed with observation after radical prostatectomy (prostate surgery), while those with high genomic risk (as determined by Decipher) may be better managed earlier with adjuvant radiotherapy.
Recent research has shown that bone health is compromised in people with diabetes, resulting in a significantly higher risk of fragility fracture.
Albireo AB, a biopharmaceutical company specializing in gastroenterology, today announced that A4250 (an inhibitor of the ileal bile acid transporter, IBAT/ASBT) has been granted orphan-drug designation by the U.S Food and Drug Administration for the treatment of Progressive Familial Intrahepatic Cholestasis (PFIC) and Primary Biliary Cirrhosis (PBC).
› Verified 7 days ago
Anas Abdel Azim, M.D., M.SC Surgery Medicare: Accepting Medicare Assignments Practice Location: 160 Academy Ave, Greenwood, SC 29646 Phone: 864-223-8090 Fax: 864-223-4026 | |
Edward Joseph Rapp Ii, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 105 Vinecrest Ct, Ste 500, Greenwood, SC 29646 Phone: 864-227-8932 Fax: 864-227-8973 | |
Dr. Kevin Wright Carson, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 160 Academy Ave, Greenwood, SC 29646 Phone: 864-223-8090 Fax: 864-223-4026 | |
Jeffrey E Lanford, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 160 Academy Ave, Greenwood, SC 29646 Phone: 864-223-8090 Fax: 864-223-4026 | |
John David Konsek, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 160 Academy Ave, Greenwood, SC 29646 Phone: 864-223-8090 Fax: 864-223-4026 | |
Dr. Ryan Joseph Bolt, DO Surgery Medicare: Medicare Enrolled Practice Location: 160 Academy Ave, Greenwood, SC 29646 Phone: 864-223-8090 | |
Dr. Jeffrey Bernard Thomas, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 160 Academy Ave, Greenwood, SC 29646 Phone: 864-223-8090 |